Nonpharmacologic and OTC therapies for chronic constipation

Advanced Studies in Medicine

Volumn 6, Issue 2 A, 2006, Pages

  Hasler, William L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE DERIVATIVE; BISACODYL; BOTULINUM TOXIN; CASCARA; CASTOR OIL; DOCUSATE SODIUM; ENEMA; FRANGULA EXTRACT; GLYCOLAX; ISPAGULA; LACTULOSE; LAXATIVE; LOPERAMIDE; LUBRICATING AGENT; MACROGOL 3350; MAGNESIUM HYDROXIDE; MAGNESIUM SALT; METHYLCELLULOSE; MINERAL OIL; NON PRESCRIPTION DRUG; OSMOTIC AGENT; PHOSPHATE; POLYCARBOPHIL CALCIUM; SENNA EXTRACT; SODIUM DIHYDROGEN PHOSPHATE; SORBITOL; TEGASEROD;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COLON CANCER; COLON DILATATION; COLON DISEASE; COLON RESECTION; COMA; CONFERENCE PAPER; CONSTIPATION; DEFECATION DISORDER; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE EXACERBATION; DYSSYNERGIC DEFECATION; EXERCISE; FEEDBACK SYSTEM; FEMALE; FLUID INTAKE; HEART DISEASE; HUMAN; HYPERNATREMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOTENSION; ISCHEMIA; LIFESTYLE; META ANALYSIS; METABOLIC ACIDOSIS; METABOLIC DISORDER; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; PARALYTIC ILEUS; PRESCRIPTION; SIDE EFFECT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 33645568967     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (70)

1. Klauser AG, Beck A, Schindlbeck NE, Muller-Lissner SA. Low fluid intake lowers stool output in healthy male volunteers. Z Gastroenterol. 1990;28:606-609.
2. Chung BD, Parekh U, Sellin JH. Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol. 1999;28:29-32.
3. Meshkinpour H, Selod S, Moyahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci. 1998;43:2379-2383.
4. Tuteja AK, Talley NJ, Joos SK, et al. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol. 2005;100:124-129.
5. Spiller RC. Pharmacology of dietary fiber. Pharmacol Ther. 1994;62:407-427.
6. Payler DK, Pomare EW, Heaton KW, Harvey RF. The effect of wheat bran on intestinal transit. Gut. 1975;16:209-213.
7. Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci. 1995;40:349-356.
8. Graham DY, Moser SE, Estes MK. The effect of bran on bowel function in constipation. Am J Gastroenterol. 1982;77:599-603.
9. Andersson H, Bosaeus J, Falkheden T, Melkersson M. Transit time in constipated geriatric patients during treatment with a bulk laxative and bran: a comparison. Scand J Gastroenterol. 1979;14:821-826.
10. Prior A, Whorwell PJ. Double blind study of ispaghula in irritable bowel syndrome. Gut. 1987;28:1510-1513.
11. Ashraf W, Park F, Lof J, Quigley EM. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther. 1995;9:639-647.
12. Davies GJ, Dettmar PW, Hoare RC. The influence of ispaghula husk on bowel habit. JR Soc Health. 1998;118:267-271.
13. Pallotta N, Rubinetto MP, Zaccaro C, et al. Calcium polycarbophil in clinical practice. The therapy of constipation. Minerva Gastroenterol Dietol. 1993;39:175-178.
14. Snape WJ Jr. The effect of methylcellulose on symptoms of constipation. Clin Ther. 1989;11:572-579.
15. Hamilton JW, Wagner J, Burdick BB, Bass P. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci. 1988;33:993-998.
16. Hotz J, Plein K. Effectiveness of plontago seed husks in comparison with wheat bran on stool frequency and manifestations of irritable colon syndrome with constipation. Med Klin (Munich). 1994;89:645-651.
17. Voderholzer WA, Schatke W, Muhldorfer BE, et al. Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol. 1997;92:95-98.
18. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002;47:2222-2230.
19. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936-971.
20. McRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther. 1998;12:491-497.
21. Preston DM, Lennard-Jones JE. Pelvic motility and response to intraluminal bisacodyl in slow-transit constipation. Dig Dis Sci. 1985;30:289-284.
22. De Schryver AM, Samsom M, Smout AI. Effects of a meal and bisacodyl on colonic motility in healthy volunteers and patients with slow-transit constipation. Dig Dis Sci. 2003;48:1206-1212.
23. Ewe K, Ueberschaer B, Press AG. Influence of senna, fibre, and fibre + senna on colonic transit in loperamide-induced constipation. Pharmacology. 1993;47(suppl 1):242-248.
24. Maddi VI. Regulation of bowel function by a laxative/stool softener preparation in aged nursing home patients. J Am Geriatr Soc. 1979;27:464-468.
25. Marlett JA, Li BU, Patrow CJ, Bass P. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. Am J Gastroenterol. 1987;82:333-337.
26. Dettmar PW, Sykes J. A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation. Curr Med Res Opin. 1998;14:227-233.
27. Kinnunen O, Winblad I, Koistinen P, Salokannel J. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology. 1993;47(suppl 1):253-255.
28. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ. 1993;307:769-771.
29. Rause M, Chapman N, Mahapatra M, et al. An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults. Br J Clin Pract. 1991;45:28-30.
30. Lederle FA, Busch DL, Mattox KM, et al. Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. Am J Med. 1990;89:597-601.
31. Sanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc. 1978;26:236-239.
32. Herve S, Leroi AM, Mathiex-Fortunet H, et al. Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity. Eur J Gastroenterol Hepatol. 2001;13:647-654.
33. Cleveland MV, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001;94:478-481.
34. DiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95:446-450.
35. Fritz E, Hammer HF, Lipp RW, et al. Effects of lactulose and polyethylene glycol on colonic transit. Aliment Pharmacol Ther. 2005;21:259-268.
36. Voskuijl W, de Lorijn F, Verwijs W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004;53:1590-1594.
37. Attar A, Lemann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999;44:226-230.
38. Riecken EO, Zeitz M, Emde C, et al. The effect of an anthraquinone laxative on colonic nerve tissue: a controlled trial in constipated women. Z Gastroenterol. 1990;28:660-664.
39. Joo JS, Ehrenpreis ED, Gonzalez L, et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol. 1998;26:283-286.
40. Watanabe T, Nakaya N, Kurashima K, et al. Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study. Eur J Cancer. 2004;40:2109-2115.
41. Roberts MC, Millikan RC, Galanko JA, et al. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol. 2003;98:857-864.
42. Sonnenberg A, Muller AD. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology. 1993;47(suppl 1):224-233.
43. Heymen S, Jones KR, Scarlett Y, Whitehead WE. Biofeedback treatment of constipation: a critical review. Dis Colon Rectum. 2003;46:1208-1217.
44. Rao SS, Welcher KD, Pelsang RE. Effects of biofeedback therapy on anorectal function in obstructive defecation. Dig Dis Sci. 1997;42:2197-2205.
45. Battaglia E, Serra AM, Buonafede G, et al. Long-term study on the effects of visual biofeedback and muscle training as a therapeutic modality in pelvic floor dyssynergia and slow-transit constipation. Dis Colon Rectum. 2004;47:90-95.
46. Wang J, Luo MH, Qi QH, Dong ZL. Prospective study of biofeedback retraining in patients with chronic idiopathic functional constipation. World J Gastroenterol. 2003;9:2109-2113.
47. Ferrara A, De Jesus S, Gallagher JT, et al. Time-related decay of the benefits of biofeedback therapy. Tech Coloproctol. 2001;5:131-135.
48. Fernandez-Fraga X, Azpiroz F, Casaus M, et al. Responses of anal constipation to biofeedback treatment. Scand J Gastroenterol. 2005;40:20-27.
49. McKee RF, McEnroe L, Anderson JH, Finley IG. Identification of patients likely to benefit from biofeedback for outlet obstruction constipation. Br J Surg. 1999;86:355-359.
50. Gilliland R, Heymen S, Altomare DF, et al. Outcome and predictors of success of biofeedback for constipation. Br J Surg. 1997;84:1123-1126.
51. Chiotakakou-Faliakou E, Kamm MA, Roy AJ, et al. Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut. 1998;42:517-521.
52. Kessler H, Hohenberger W. Laparoscopic total colectomy for slow-transit constipation. Dis Colon Rectum. 2005;48:860-861.
53. Kalbassi MR, Winter DC, Deasy JM. Quality-of-life assessment of patients after ileal pouch-anal anastomosis for slow-transit constipation with rectal inertia. Dis Colon Rectum. 2003;46:1508-1512.
54. Fitz-Harris GP, Garcia-Aguilar J, Parker SC, et al. Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count. Dis Colon Rectum. 2003;46:433-440.
55. Verne GN, Hocking MP, Davis RH, et al. Long-term response to subtotal colectomy in colonic inertia. J Gastrointest Surg. 2000;6:738-744.
56. Webster C, Dayton M. Results after colectomy for colonic inertia: a sixteen-year experience. Am J Surg. 2001;182:639-644.
57. Mollen RM, Kuijpers HC, Claassen AT. Colectomy for slow-transit constipation: postoperative functional evaluation is important but not a guarantee for a successful outcome. Dis Colon Rectum. 2001;44:577-580.
58. Pikarsky AJ, Singh JJ, Weiss EG, et al. Long-term follow-up of patients undergoing colectomy for colonic inertia. Dis Colon Rectum. 2001;44:179-183.
59. Scarpa M, Barollo M, Keighley MR. Ileostomy for constipation: long-term postoperative outcome. Colorectal Dis. 2005;7:224-227.
60. Bernini A, Madoff RD, Lowry AC, et al. Should patients with combined colonic inertia and nonrelaxing pelvic floor undergo subtotal colectomy? Dis Colon Rectum. 1998;41:1363-1366.
61. Hirst GR, Hughes RJ, Morgan AR, et al. The role of rectocele repair in targeted patients with obstructed defecation. Colorectal Dis. 2005;7:159-163.
62. Sloots CE, Meulen AJ, Felt-Bersma RJ. Rectocele repair improves evacuation and prolapse complaints independent of anorectal function and colonic transit time. Int J Colorectal Dis. 2003;18:342-348.
63. Lopez A, Anzen B, Bremmer S, et al. Durability of response after rectocele repair. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12:97-103.
64. Van Dam JH, Huisman WM, Hop WC, Schouten WR. Fecal continence after rectocele repair: a prospective study. Int J Colorectal Dis. 2000;15:54-57.
65. Mellgren A, Anzen B, Nilsson BY, et al. Results of rectocele repair. A prospective study. Dis Colon Rectum. 1995;38:7-13.
66. Tsiaoussis J, Chrysos E, Athanasakis E, et al. Rectoanal intussusception: presentation of the disorder and late results of resection rectopexy. Dis Colon Rectum. 2005;48:838-844.
67. Boccasanta P, Venturi M, Stuto A, et al. Stapled transanal rectal resection for outlet obstruction: a prospective, multicenter trial. Dis Colon Rectum. 2004;47:1285-1296.
68. Johnson E, Carlsen E, Mjaland O, Drolsum A. Resection retropexy for internal rectal intussusception reduces constipation and incomplete evacuation of stool. Eur J Surg Suppl. 2003;588:51-56.
69. Rao SS, Kinkade K, Schulze K, et al. Biofeedback therapy (BT) for dyssynergic constipation-randomized controlled trial. Gastroenterology. 2005;128:S1851.
70. Chiarioni G, Salandini L, Whitehead WF. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129:86-97.